DK0531078T3 - (R)-3-methoxy-4-(1-methyl-5-(2-methyl-4,4,4-trifluorbutylcarbamoyl)indol-3-ylmethyl)-N- (2-methylphenylsulfonyl)benzamid i krystallinsk form - Google Patents
(R)-3-methoxy-4-(1-methyl-5-(2-methyl-4,4,4-trifluorbutylcarbamoyl)indol-3-ylmethyl)-N- (2-methylphenylsulfonyl)benzamid i krystallinsk formInfo
- Publication number
- DK0531078T3 DK0531078T3 DK92307903.2T DK92307903T DK0531078T3 DK 0531078 T3 DK0531078 T3 DK 0531078T3 DK 92307903 T DK92307903 T DK 92307903T DK 0531078 T3 DK0531078 T3 DK 0531078T3
- Authority
- DK
- Denmark
- Prior art keywords
- methyl
- trifluorobutylcarbamoyl
- ylmethyl
- methoxy
- benzamide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D209/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with an alkyl or cycloalkyl radical attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919119001A GB9119001D0 (en) | 1991-09-05 | 1991-09-05 | Pharmaceutical agents |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0531078T3 true DK0531078T3 (da) | 1996-10-14 |
Family
ID=10700953
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92307903.2T DK0531078T3 (da) | 1991-09-05 | 1992-09-01 | (R)-3-methoxy-4-(1-methyl-5-(2-methyl-4,4,4-trifluorbutylcarbamoyl)indol-3-ylmethyl)-N- (2-methylphenylsulfonyl)benzamid i krystallinsk form |
Country Status (21)
Country | Link |
---|---|
US (2) | US5352694A (da) |
EP (1) | EP0531078B1 (da) |
JP (1) | JP2914414B2 (da) |
KR (1) | KR100254710B1 (da) |
AT (1) | ATE138910T1 (da) |
AU (1) | AU646587B2 (da) |
CA (1) | CA2076722A1 (da) |
CZ (1) | CZ281999B6 (da) |
DE (1) | DE69211258T2 (da) |
DK (1) | DK0531078T3 (da) |
FI (1) | FI102372B (da) |
GB (2) | GB9119001D0 (da) |
HK (1) | HK18297A (da) |
HU (2) | HU213410B (da) |
IL (1) | IL102856A (da) |
NO (1) | NO178370C (da) |
NZ (1) | NZ244016A (da) |
RU (1) | RU2095348C1 (da) |
SK (1) | SK267092A3 (da) |
TW (1) | TW302359B (da) |
ZA (1) | ZA926374B (da) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5958780A (en) | 1997-06-30 | 1999-09-28 | Boston Advanced Technologies, Inc. | Method for marking and identifying liquids |
US6149914A (en) * | 1999-07-12 | 2000-11-21 | Patel; Jitendra Rambhai | Asthma treatment |
TWI353979B (en) * | 2002-04-10 | 2011-12-11 | Nippon Zoki Pharmaceutical Co | Novel crystal form of 5-hydroxy-1-methylhydantoin |
EP1997491B1 (en) | 2004-07-14 | 2010-09-22 | Inflammation Research Center Company Ltd. | Method for inhibiting tumor metastasis |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4524152A (en) * | 1982-12-30 | 1985-06-18 | Pennwalt Corporation | 1-Cyano-3-(fluoroalkyl)guanidines for lowering blood pressure |
GB8623429D0 (en) * | 1985-10-17 | 1986-11-05 | Ici America Inc | Carboximide derivatives |
MY103259A (en) * | 1987-04-15 | 1993-05-29 | Ici America Inc | Aliphatic carboxamides |
GB8906032D0 (en) * | 1988-04-14 | 1989-04-26 | Ici America Inc | Hetera-aliphatic carboxamides |
GB8927981D0 (en) * | 1989-12-11 | 1990-02-14 | Ici Plc | Carbamoyl derivative |
GB9026425D0 (en) * | 1990-12-05 | 1991-01-23 | Ici Plc | Process |
GB9026427D0 (en) * | 1990-12-05 | 1991-01-23 | Ici Plc | Chemical process |
GB9027018D0 (en) * | 1990-12-12 | 1991-01-30 | Ici Plc | Heterocyclic compounds |
IL100091A (en) * | 1990-12-12 | 1998-08-16 | Zeneca Ltd | Pharmaceutical preparations containing the physical form of [4] 5) Cyclopentyloxycarbyl (amino 1 methyl indole 3 methyl methyl [3 methoxybenzoyl [2 methylbenzole) |
-
1991
- 1991-09-05 GB GB919119001A patent/GB9119001D0/en active Pending
-
1992
- 1992-08-07 GB GB929216774A patent/GB9216774D0/en active Pending
- 1992-08-14 AU AU21012/92A patent/AU646587B2/en not_active Ceased
- 1992-08-17 HU HU9202660A patent/HU213410B/hu not_active IP Right Cessation
- 1992-08-18 IL IL10285692A patent/IL102856A/en not_active IP Right Cessation
- 1992-08-19 NZ NZ244016A patent/NZ244016A/xx unknown
- 1992-08-24 ZA ZA926374A patent/ZA926374B/xx unknown
- 1992-08-24 CA CA002076722A patent/CA2076722A1/en not_active Abandoned
- 1992-08-28 FI FI923869A patent/FI102372B/fi not_active IP Right Cessation
- 1992-08-28 TW TW081106814A patent/TW302359B/zh active
- 1992-08-28 CZ CS922670A patent/CZ281999B6/cs not_active IP Right Cessation
- 1992-08-28 SK SK2670-92A patent/SK267092A3/sk unknown
- 1992-09-01 DK DK92307903.2T patent/DK0531078T3/da active
- 1992-09-01 DE DE69211258T patent/DE69211258T2/de not_active Expired - Lifetime
- 1992-09-01 AT AT92307903T patent/ATE138910T1/de not_active IP Right Cessation
- 1992-09-01 EP EP92307903A patent/EP0531078B1/en not_active Expired - Lifetime
- 1992-09-03 US US07/940,138 patent/US5352694A/en not_active Expired - Lifetime
- 1992-09-04 KR KR1019920016075A patent/KR100254710B1/ko not_active IP Right Cessation
- 1992-09-04 JP JP4237273A patent/JP2914414B2/ja not_active Expired - Fee Related
- 1992-09-04 RU SU925052928A patent/RU2095348C1/ru not_active IP Right Cessation
- 1992-09-04 NO NO923467A patent/NO178370C/no not_active IP Right Cessation
-
1994
- 1994-06-17 US US08/261,607 patent/US5466826A/en not_active Expired - Lifetime
-
1995
- 1995-06-09 HU HU95P/P00182P patent/HU210879A9/hu unknown
-
1997
- 1997-02-13 HK HK18297A patent/HK18297A/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL167168A (en) | Indoline compound in crystalline form for use in oral solid medicament and such oral solid medicament for treating dysuria | |
AU683442B2 (en) | Aminoacid derivates, medicaments containing these compounds and process for preparing the same | |
CA2296604A1 (en) | Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use | |
KR970703333A (ko) | 5-HT_1A 길항제로서의 피페라진 유도체(Piperazine derivatives as 5-HT_1A antagonists) | |
NZ242104A (en) | Amides of aminoethylsubstituted benzothiazole, -thiazine, -oxazole and -oxazine derivatives; pharmaceutical compositions thereof | |
NO912511L (no) | Fremgangsmaate for forhindring eller begrensning av reperfusjonsskade | |
DK0531078T3 (da) | (R)-3-methoxy-4-(1-methyl-5-(2-methyl-4,4,4-trifluorbutylcarbamoyl)indol-3-ylmethyl)-N- (2-methylphenylsulfonyl)benzamid i krystallinsk form | |
CA2205573A1 (en) | Enterokinetic benzamide | |
FI933719A0 (fi) | 4-((2-bensotiazolyl)metylamino)-a-((3,4-difluorfenoxi)metyl)-1-piperidinetanol | |
NO910904D0 (no) | Fremgangsmaate for fremstilling av en substituert aminforbindelse. | |
MXPA04000620A (es) | Uso de derivados de tiazol para elaboracion de medicamento para tratamiento de enfermedad pulmonar obstructiva cronica. | |
ES2062940A1 (es) | Agente gastrocinetico, proceso para su preparacion y composiciones farmaceuticas que lo contengan. | |
CA2622808C (en) | Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |